[ITCI] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -16.42%
YoY- -22.14%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 94,731 87,433 71,870 55,074 34,755 25,516 21,606 168.12%
PBT -44,043 -44,026 -53,507 -86,603 -72,114 -85,734 -76,931 -31.07%
Tax 10 -6,772 1 -2,640 5 -541 -23 -
NP -44,053 -37,254 -53,508 -83,963 -72,119 -85,734 -76,908 -31.05%
Tax Rate - - - - - - - -
Total Cost 138,784 124,687 125,378 139,037 106,874 111,250 98,514 25.69%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -46.50 -42.61 -74.45 -152.45 -207.51 -336.00 -355.95 -74.28%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.46 -0.39 -0.57 -0.89 -0.78 -1.05 -0.95 -38.36%
EPS Diluted -0.46 -0.39 -0.57 -0.89 -0.78 -1.05 -0.95 -38.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.